Lindsay Yount King, MD

Assistant Professor of Medicine
Email address lindsay.king@duke.edu
In Their Words

Education and Training

  • Advanced Transplant Hepatology Fellowship, Medicine, Massachusetts General Hospital, 2014 - 2015
  • Clinical & Research Fellowship in Gastroenterology, Medicine, Massachusetts General Hospital, 2010 - 2014
  • Internal Medicine Residency, Medicine, Brigham and Women's Hospital, 2006 - 2009
  • M.P.H., Harvard University , 2014
  • M.D., University of Virginia School of Medicine, 2006

Publications

Moon, Andrew M., Zachary Spiritos, Lindsay Y. King, and A Sidney Barritt. “Immunosuppression in Autoimmune Hepatitis: Is There an End Game?” Am J Gastroenterol 115, no. 4 (April 2020): 498–501. https://doi.org/10.14309/ajg.0000000000000538.

PMID
32032074
Full Text

Shropshire, Erin L., Mohammad Chaudhry, Chad M. Miller, Brian C. Allen, Erol Bozdogan, Diana M. Cardona, Lindsay Y. King, et al. “LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.” Radiology 292, no. 1 (July 2019): 226–34. https://doi.org/10.1148/radiol.2019182135.

PMID
31038409
Full Text

Ma, Yanan, Tracey G. Simon, Fred K. Tabung, Lindsay Y. King, Dawn Q. Chong, Long Nguyen, Trang VoPham, et al. “Abstract 5256: A prospective study of inflammatory diet potential and risk of hepatocellular carcinoma (HCC).” In Epidemiology. American Association for Cancer Research, 2018. https://doi.org/10.1158/1538-7445.am2018-5256.

Full Text

Patel, Yuval A., Kara Wegermann, Carl L. Berg, and Lindsay Y. King. “Patient 1 with decompensated nonalcoholic steatohepatitis cirrhosis with inability to lose weight should undergo transplantation.” Clin Liver Dis (Hoboken) 11, no. 6 (June 2018): 149–51. https://doi.org/10.1002/cld.703.

PMID
30992806
Full Text

Simon, Tracey G., Lindsay Y. King, Dawn Q. Chong, Long H. Nguyen, Yanan Ma, Trang VoPham, Edward L. Giovannucci, et al. “Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.” Hepatology 67, no. 5 (May 2018): 1797–1806. https://doi.org/10.1002/hep.29660.

PMID
29152763
Full Text

Henson, Jacqueline B., Yuval A. Patel, Julius M. Wilder, Jiayin Zheng, Shein-Chung Chow, Lindsay Y. King, and Andrew J. Muir. “Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.” Dig Dis Sci 62, no. 11 (November 2017): 3200–3209. https://doi.org/10.1007/s10620-017-4559-1.

PMID
28391417
Full Text

Simon, Tracey G., Lindsay Y. King, Dawn Q. Chong, Yanan Ma, Hamed Khalili, Raymond T. Chung, Xuehong Zhang, and Andrew T. Chan. “Diabetes, duration of diabetes, use of anti-diabetic medications, and risk of hepatocellular carcinoma.” In Hepatology, 66:759A-760A. WILEY, 2017.

Scholars@Duke

Henson, Jacqueline B., Yuval A. Patel, Lindsay Y. King, Jiayin Zheng, Shein-Chung Chow, and Andrew J. Muir. “Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.” Liver Transpl 23, no. 6 (June 2017): 769–80. https://doi.org/10.1002/lt.24703.

PMID
28027592
Full Text

Goossens, Nicolas, Amit G. Singal, Lindsay Y. King, Karin L. Andersson, Bryan C. Fuchs, Cecilia Besa, Bachir Taouli, Raymond T. Chung, and Yujin Hoshida. “Cost-effectiveness of a risk-stratified hepatocellular carcinoma surveillance strategy in patients with cirrhosis.” In Hepatology, 64:630A-630A. WILEY, 2016.

Scholars@Duke

Henson, Jacqueline B., Julius M. Wilder, Yuval A. Patel, Jiayin Zheng, Shein-Chung Chow, Lindsay Y. King, and Andrew J. Muir. “Phenotypic Differences in Primary Sclerosing Cholangitis by Age Group.” In Hepatology, 64:185A-185A. WILEY, 2016.

Scholars@Duke

Pages